Flagship Harbor Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,961	Closed	-$155K	–	1014
2025 Q4	$155K	Buy	+2,961	New	+$177K	0.01%	743
2024 Q4	–	Sell	-6,073	Closed	-$285K	–	746
2024 Q3	$285K	Sell	6,073 -195	-3%	-$9.89K	0.02%	575
2024 Q2	$339K	Sell	6,268 -285	-4%	-$16.5K	0.02%	506
2024 Q1	$447K	Sell	6,553 -43	-0.7%	-$3.08K	0.03%	411
2023 Q4	$413K	Buy	6,596 +574	+10%	+$31.7K	0.03%	405
2023 Q3	$273K	Buy	6,022 +209	+4%	+$10.8K	0.02%	492
2023 Q2	$326K	Buy	5,813 +547	+10%	+$31K	0.03%	450
2023 Q1	$238K	Buy	5,266 +200	+4%	+$9.71K	0.02%	544
2022 Q4	$206K	Buy	5,066 +50	+1%	+$2.65K	0.02%	566
2022 Q3	$328K	Sell	5,016 -36	-0.7%	-$2.61K	0.04%	416
2022 Q2	$307K	Sell	5,052 -72	-1%	-$4.23K	0.03%	453
2022 Q1	$322K	Buy	5,124 +233	+5%	+$14.6K	0.03%	460
2021 Q4	$371K	Buy	4,891 +283	+6%	+$24.7K	0.04%	442
2021 Q3	$746K	Hold	4,608	–	–	0.08%	266
2021 Q2	$746K	Buy	4,608 +1,497	+48%	+$182K	0.08%	267
2021 Q1	$379K	Buy	3,111 +46	+2%	+$6.95K	0.04%	412
2020 Q4	$469K	Buy	3,065 +55	+2%	+$6.5K	0.06%	327
2020 Q3	$251K	Sell	3,010 -690	-19%	-$61.2K	0.03%	410
2020 Q2	$271K	Buy	3,700 +150	+4%	+$8.77K	0.04%	382
2020 Q1	$151K	Buy	3,550 +883	+33%	+$45.6K	0.03%	447
2019 Q4	$162K	Sell	2,667 -42	-2%	-$2.29K	0.03%	485
2019 Q3	$111K	Sell	2,709 -600	-18%	-$28.7K	0.02%	555
2019 Q2	$155K	Hold	3,309	–	–	0.03%	458
2019 Q1	$118K	Buy	3,309 +600	+22%	+$20.7K	0.02%	519
2018 Q4	$77K	Buy	2,709 +2,443	+918%	+$84.9K	0.02%	592
2018 Q3	$11K	Sell	266 -100	-27%	-$5.24K	﹤0.01%	1367
2018 Q2	$21K	Buy	+366	New	+$20.9K	﹤0.01%	1072